<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:0b4e1244-1fc3-47d8-8be0-f57ee9e89ff0,g:97a0a858-4b5a-4c0d-affa-b29560ff7ac3,d:d188c0b296654a1b8dbb8f3d20ea891c--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vrdn-20210506</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xMy9mcmFnOjk0MGY5NTZjMDg3NzQyNmViY2QxMDIxMzEwY2M1OGZkL3RhYmxlOmU3OGRmNzQ4OGY5ODRkYzliNDc1ZWFmNWZiOGExNDRmL3RhYmxlcmFuZ2U6ZTc4ZGY3NDg4Zjk4NGRjOWI0NzVlYWY1ZmI4YTE0NGZfMC0xLTEtMS0w_b73050fe-c53a-493f-b94a-93b6571c5ba8">Viridian Therapeutics, Inc.\DE</ix:nonNumeric><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xMy9mcmFnOjk0MGY5NTZjMDg3NzQyNmViY2QxMDIxMzEwY2M1OGZkL3RhYmxlOmU3OGRmNzQ4OGY5ODRkYzliNDc1ZWFmNWZiOGExNDRmL3RhYmxlcmFuZ2U6ZTc4ZGY3NDg4Zjk4NGRjOWI0NzVlYWY1ZmI4YTE0NGZfMS0xLTEtMS0w_cb00fb89-e521-4497-b7e0-c63ebf9d80e0">false</ix:nonNumeric><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xMy9mcmFnOjk0MGY5NTZjMDg3NzQyNmViY2QxMDIxMzEwY2M1OGZkL3RhYmxlOmU3OGRmNzQ4OGY5ODRkYzliNDc1ZWFmNWZiOGExNDRmL3RhYmxlcmFuZ2U6ZTc4ZGY3NDg4Zjk4NGRjOWI0NzVlYWY1ZmI4YTE0NGZfNS0xLTEtMS0w_6dee8c68-9a67-4643-85a7-e6100e6a453c">0001590750</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vrdn-20210506.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib8700829394f439581e559bba16eb5c7_D20210506-20210506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001590750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-06</xbrli:startDate><xbrli:endDate>2021-05-06</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id188c0b296654a1b8dbb8f3d20ea891c_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGV4dHJlZ2lvbjo3MjA5ZDk4M2YzYTQ0MTU0OWNlZmE0MWY1OTIyMjBjNF8xMjM0_09c1d2b8-faee-45f8-aa1f-00140a10fbeb">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-bottom:3pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGV4dHJlZ2lvbjo3MjA5ZDk4M2YzYTQ0MTU0OWNlZmE0MWY1OTIyMjBjNF8yMjQ_e4fd2d8b-ea2f-416e-8e34-b1cd518ddcc8">May 6, 2021</ix:nonNumeric></span></div><div style="text-align:center"><img src="vrdn-20210506_g1.jpg" alt="vrdn-20210506_g1.jpg" style="height:36px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%">VIRIDIAN THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.452%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6NTJjYzk0ZTFmNTgyNGY0MWE0YmRhOThkZGZjMDJjN2QvdGFibGVyYW5nZTo1MmNjOTRlMWY1ODI0ZjQxYTRiZGE5OGRkZmMwMmM3ZF8wLTAtMS0xLTA_b8cf3b6f-313a-43ed-bd4f-26868ebb258f">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6NTJjYzk0ZTFmNTgyNGY0MWE0YmRhOThkZGZjMDJjN2QvdGFibGVyYW5nZTo1MmNjOTRlMWY1ODI0ZjQxYTRiZGE5OGRkZmMwMmM3ZF8wLTItMS0xLTA_38fa8842-8140-4fc5-a4d5-53fea7f8ab56">001-36483</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6NTJjYzk0ZTFmNTgyNGY0MWE0YmRhOThkZGZjMDJjN2QvdGFibGVyYW5nZTo1MmNjOTRlMWY1ODI0ZjQxYTRiZGE5OGRkZmMwMmM3ZF8wLTQtMS0xLTA_624971ed-4141-46a8-af9a-dabc88cd9cdd">47-1187261</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6Nzc1NDhlNzNjOWJkNGI5MGE4MDcyZDQ3ZmYxYjNmOGUvdGFibGVyYW5nZTo3NzU0OGU3M2M5YmQ0YjkwYTgwNzJkNDdmZjFiM2Y4ZV8wLTEtMS0xLTA_23cc1688-f664-477f-8c48-6d28f92162ce">6200 Lookout Rd.</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6Nzc1NDhlNzNjOWJkNGI5MGE4MDcyZDQ3ZmYxYjNmOGUvdGFibGVyYW5nZTo3NzU0OGU3M2M5YmQ0YjkwYTgwNzJkNDdmZjFiM2Y4ZV8xLTEtMS0xLTA_83f9cc6b-d082-4246-9649-f3820b1e8a7f">Boulder</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6Nzc1NDhlNzNjOWJkNGI5MGE4MDcyZDQ3ZmYxYjNmOGUvdGFibGVyYW5nZTo3NzU0OGU3M2M5YmQ0YjkwYTgwNzJkNDdmZjFiM2Y4ZV8xLTItMS0xLTA_9a099f06-fd5f-4d66-b8eb-8b678b5f06a5">CO</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6Nzc1NDhlNzNjOWJkNGI5MGE4MDcyZDQ3ZmYxYjNmOGUvdGFibGVyYW5nZTo3NzU0OGU3M2M5YmQ0YjkwYTgwNzJkNDdmZjFiM2Y4ZV8xLTUtMS0xLTA_902f03aa-ea49-4379-b115-0bcc678532ee">80301</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGV4dHJlZ2lvbjo3MjA5ZDk4M2YzYTQ0MTU0OWNlZmE0MWY1OTIyMjBjNF8xMjM3_64b607e8-12ca-495d-a2da-86079d205fe0">720</ix:nonNumeric>) <ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGV4dHJlZ2lvbjo3MjA5ZDk4M2YzYTQ0MTU0OWNlZmE0MWY1OTIyMjBjNF8xMjM4_c2aac644-656d-4875-9bfa-cf0372e689b1">643-5200</ix:nonNumeric>&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report) </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions: </span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6NTAzZDQ0YWNmMDgxNGQwMDhjMmQzOTY1YWU4NGEyOGIvdGFibGVyYW5nZTo1MDNkNDRhY2YwODE0ZDAwOGMyZDM5NjVhZTg0YTI4Yl8wLTAtMS0xLTA_132087ad-aa67-4d27-84db-ce0252575e73">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6NTAzZDQ0YWNmMDgxNGQwMDhjMmQzOTY1YWU4NGEyOGIvdGFibGVyYW5nZTo1MDNkNDRhY2YwODE0ZDAwOGMyZDM5NjVhZTg0YTI4Yl8xLTAtMS0xLTA_77ed474d-57c5-46f1-8f44-77bd06b67c9a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6NTAzZDQ0YWNmMDgxNGQwMDhjMmQzOTY1YWU4NGEyOGIvdGFibGVyYW5nZTo1MDNkNDRhY2YwODE0ZDAwOGMyZDM5NjVhZTg0YTI4Yl8yLTAtMS0xLTA_46d78a08-c711-4ae8-8274-e89a52c091c1">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6NTAzZDQ0YWNmMDgxNGQwMDhjMmQzOTY1YWU4NGEyOGIvdGFibGVyYW5nZTo1MDNkNDRhY2YwODE0ZDAwOGMyZDM5NjVhZTg0YTI4Yl8zLTAtMS0xLTA_c5595786-d34a-4d68-b78f-c0b405c25afc">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange<br/>on which registered</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6Yzg4OGQ4MmU0MzNmNDc4MzgyYTc5YzcxNTEyYjUxZmMvdGFibGVyYW5nZTpjODg4ZDgyZTQzM2Y0NzgzODJhNzljNzE1MTJiNTFmY18xLTAtMS0xLTA_3d91007c-ecca-4221-8d81-1e5c0f685efc">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6Yzg4OGQ4MmU0MzNmNDc4MzgyYTc5YzcxNTEyYjUxZmMvdGFibGVyYW5nZTpjODg4ZDgyZTQzM2Y0NzgzODJhNzljNzE1MTJiNTFmY18xLTMtMS0xLTA_a8e736c8-feff-4d69-8444-4b71027c264a">VRDN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGFibGU6Yzg4OGQ4MmU0MzNmNDc4MzgyYTc5YzcxNTEyYjUxZmMvdGFibGVyYW5nZTpjODg4ZDgyZTQzM2Y0NzgzODJhNzljNzE1MTJiNTFmY18xLTUtMS0xLTA_523a4600-76c1-48a9-94b2-408505bc380b">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter). </span></div><div style="margin-top:10pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib8700829394f439581e559bba16eb5c7_D20210506-20210506" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmQxODhjMGIyOTY2NTRhMWI4ZGJiOGYzZDIwZWE4OTFjL3NlYzpkMTg4YzBiMjk2NjU0YTFiOGRiYjhmM2QyMGVhODkxY18xL2ZyYWc6NzIwOWQ5ODNmM2E0NDE1NDljZWZhNDFmNTkyMjIwYzQvdGV4dHJlZ2lvbjo3MjA5ZDk4M2YzYTQ0MTU0OWNlZmE0MWY1OTIyMjBjNF8xMjMz_2c7c6f53-fe4c-4745-aa02-215fa5f3065c">&#9744;</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id188c0b296654a1b8dbb8f3d20ea891c_4"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 2 - Financial Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;6, 2021, Viridian Therapeutics, Inc., issued a press release reporting financial results for the three months ended March&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this Current Report on Form 8-K and shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 9 - Financial Statements and Exhibits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.433%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Description</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20210331ex991pressrelease.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Press release, dated May 6, 2021.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id188c0b296654a1b8dbb8f3d20ea891c_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.169%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.869%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Viridian Therapeutics, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 6, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jason A. Leverone</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason A. Leverone</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer, Treasurer, and Secretary</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "vrdn-20210506.htm", "description": "8-K", "secsgml_size_bytes": 38209}]
{"company-data": {"conformed-name": "Viridian Therapeutics, Inc.\\DE", "cik": "0001590750", "assigned-sic": "8071", "irs-number": "471187261", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36483", "film-number": "21897807"}, "business-address": {"street1": "6200 LOOKOUT ROAD", "city": "BOULDER", "state": "CO", "zip": "80301", "phone": "303-531-5952"}, "mail-address": {"street1": "6200 LOOKOUT ROAD", "city": "BOULDER", "state": "CO", "zip": "80301"}, "former-company": [{"former-conformed-name": "MIRAGEN THERAPEUTICS, INC.", "date-changed": "20170213"}, {"former-conformed-name": "MIRAGEN THERAPEUTICS, INC.", "date-changed": "20170213"}, {"former-conformed-name": "SIGNAL GENETICS, INC.", "date-changed": "20140710"}]}
vrdn-20210506
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 6, 2021
VIRIDIAN THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-36483
47-1187261
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
6200 Lookout Rd.
Boulder
CO
80301
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: (
720
)
643-5200
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common Stock, $0.01 par value
VRDN
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Section 2 - Financial Information
Item 2.02 Results of Operations and Financial Condition.
On May 6, 2021, Viridian Therapeutics, Inc., issued a press release reporting financial results for the three months ended March 31, 2021.
The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this Current Report on Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "
Exchange Act
"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number
Exhibit Description
99.1
Press release, dated May 6, 2021.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Viridian Therapeutics, Inc.
Date: May 6, 2021
By:
/s/ Jason A. Leverone
Jason A. Leverone
Chief Financial Officer, Treasurer, and Secretary